规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | Tinidazole is a 5-nitroimidazole active in vitro against a wide variety of anaerobic bacteria and protozoa. Tinidazole is an effective treatment against anaerobic microorganisms based on its pharmacokinetic characteristics (Cmax 51 microg/ml, t1/2 12.5h) and its excellent in vitro activity. Its long half-life allows once a day regimens. Tinidazole was recently approved by the Food and Drug Administration (FDA) for the treatment of infections caused by Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia[3]. Since tinidazole has no activity against aerobic bacteria, it must be combined with other antibacterial agents in the treatment of mixed infections involving aerobic and anaerobic bacteria[4]. TNZ (Tinidazole) outperforms ABZ (albendazole) in the treatment of Giardia infections in children from developing countries[5]. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT02934048 | Therapeutic Duration ... 展开 >> Helicobacter Pylori Antimicrobial Susceptibility Test Eradication 收起 << | Phase 4 | Unknown | June 2017 | - |
NCT03139253 | Antimicrobial Susceptibility T... 展开 >>esting Triple Therapy 收起 << | Phase 4 | Not yet recruiting | June 30, 2017 | - |
NCT03124420 | Helicobacter Pylori Infection | Phase 4 | Completed | - | Taiwan ... 展开 >> Division of Gastroenterology and Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan Taipei, Taiwan, 10449 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
4.04mL 0.81mL 0.40mL |
20.22mL 4.04mL 2.02mL |
40.44mL 8.09mL 4.04mL |
CAS号 | 19387-91-8 |
分子式 | C8H13N3O4S |
分子量 | 247.27 |
SMILES Code | O=[N+](C1=CN=C(C)N1CCS(=O)(CC)=O)[O-] |
MDL No. | MFCD00057217 |
别名 | CP 12,574; CP12574; Tricolam; Teofarma; Simplotan; Fasygin; Fasigyne; Fasigyn; Fasigin; Farmasierra; Bioshik |
运输 | 蓝冰 |
InChI Key | HJLSLZFTEKNLFI-UHFFFAOYSA-N |
Pubchem ID | 5479 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, room temperature |
溶解方案 |
DMSO: 50 mg/mL(202.21 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 3 mg/mL(12.13 mM),配合低频超声助溶 |